Profil bibliographique

Naotoshi Sugimoto

Informations fournies par OpenAlex. Research Africa ne déduit ni nationalité, ni poste, ni coordonnées personnelles.

40Publications signalées

88Citations signalées

1Affiliations récentes

Institutions déclarées

Domaines associés

Phytochemical Studies and BioactivitiesChromatography in Natural ProductsGastric Cancer Management and OutcomesCancer Treatment and PharmacologyColorectal Cancer Treatments and Studies

Publications récentes

Accès ouvert 2026 articleOpenAlex

Phase II study of mFOLFOX6 in advanced gastric cancer patients with severe peritoneal metastases (WJOG10517G), including an individual patient data comparison with JCOG1108/WJOG7312G

Toshiki Masuishi, Hiroki Hara, Takayuki Ando, Takeshi Kawakami et autres

0 citationsGastric Cancer

Accès ouvert 2026 articleOpenAlex

Genetic and Clinical Characteristics of Patients With Tumor Mutation Burden‐High Unresectable Pancreatic Cancer and the Efficacy of Pembrolizumab Treatment

Yugo Kai, Kenji Ikezawa, Kazuhiro Kozumi, Makiko Urabe et autres

0 citationsCancer Reports

2026 articleOpenAlex

JAGUAR (JACCRO PM-01): A prospective study to evaluate the clinical utility of serial comprehensive genomic profiling testing using circulating tumor DNA in patients with metastatic colorectal cancer.

Yu Sunakawa, Toshiki Masuishi, Hiroyuki Takeda, Sho Umegaki et autres

0 citationsJournal of Clinical Oncology

2026 conference-abstractOpenAlex

Three-year and five-year outcomes of a phase II study of perioperative CapeOx therapy for advanced gastric cancer with extensive lymph node metastasis (OGSG1701).

R. Kawabata, Yutaka Kimura, Naotoshi Sugimoto, Shunji Endo et autres

0 citationsJournal of Clinical Oncology

Accès ouvert 2026 articleOpenAlex

Clinical Impact of Trastuzumab Deruxtecan in Patients With HER2-Positive Advanced Gastric Cancer and Ascites: Findings From the EN-DEAVOR Study

Keiko Minashi, Rin Inamoto, Hisato Kawakami, Koki Nakanishi et autres

0 citationsJournal of the Korean Gastric Cancer Association

2025 articleOpenAlex

2111P Two-year follow-up of the NO LIMIT study (WJOG13320G/CA209-7W7): Durable efficacy of the first-line nivolumab plus low-dose ipilimumab in MSI-H advanced gastric and esophagogastric junction cancer

H. Kawakami, S. Kadowaki, Akitaka Makiyama, Keiko Hirata et autres

0 citationsAnnals of Oncology

Accès ouvert 2025 articleOpenAlex

Pembrolizumab Plus Chemotherapy Versus Chemotherapy as Perioperative Therapy in Locally Advanced Gastric and Gastroesophageal Junction Cancer: Final Analysis of the Randomized, Phase III KEYNOTE-585 Study

Sun Young Rha, Lucjan Wyrwicz, Nina Karaseva, Hisateru Yasui et autres

42 citationsJournal of Clinical Oncology

2025 articleOpenAlex

First-line pembrolizumab plus chemotherapy for participants in Japan with gastric or gastroesophageal junction adenocarcinoma: subgroup analysis of the phase 3 KEYNOTE-859 study

Hisateru Yasui, Masaki Aizawa, Kensei Yamaguchi, Akihito Kawazoe et autres

1 citationInternational Journal of Clinical Oncology

Accès ouvert 2025 articleOpenAlex

ONO ‐4578 Plus Nivolumab in Unresectable Advanced or Recurrent Gastric or Gastroesophageal Junction Cancer

Akihito Kawazoe, Kensei Yamaguchi, Tetsuya Hamaguchi, Yukiya Narita et autres

7 citationsCancer Science

Accès ouvert 2025 articleOpenAlex

35P Clinical outcomes of modified (m)-FOLFOXIRI plus cetuximab versus bevacizumab by metastasis status in RAS/BRAF wild-type and left-sided metastatic colorectal cancer: The DEEPER trial (JACCRO CC-13)

Y. Sunakawa, M. Shiozawa, Yoshiaki Shindo, Yuichi Ishikawa et autres

1 citationAnnals of Oncology

Accès ouvert 2025 articleOpenAlex

Clinical and prognostic characteristics of metastatic colorectal cancer with minor RAS mutations

Yoshiki Kojitani, Daisuke Sakai, Takatsugu Ogata, Yumi Amano et autres

1 citationOncology Letters

Accès ouvert 2024 articleOpenAlex

The Efficacy of FOLFIRI Plus Ramucirumab in Recurrent Colorectal Cancer Refractory to Adjuvant Chemotherapy with Oxaliplatin/Fluoropyrimidine—Including Biomarker Analyses

Naotoshi Sugimoto, Shingo Noura, Takeshi Kato, Shinichi Yoshioka et autres

1 citationCancers

Profil ORCID Notice OpenAlex

BNTIC News n’est pas le producteur de ces données. Recherche à la demande dans Crossref et Europe PMC, sans clé ; OpenAlex reste optionnel. Aucun service payant requis, aucune réponse conservée. Sources et limites.